Millipore Sigma Vibrant Logo

230950 Ciglitazone - CAS 74772-77-3 - Calbiochem

View This Product on Sigma-Aldrich
230950
価格&在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
74772-77-3C₁₈H₂₃NO₃S

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
230950-5MGCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 5 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewA potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective PPARγ agonist (EC50 = 3 µM).
      Catalogue Number230950
      Brand Family Calbiochem®
      Synonyms(±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione, PPAR Agonist II, PPARγ Agonist I
      References
      ReferencesJha, R.J. 1999. Clin. Exp. Hypertens. 21, 157.
      Xin, X., et al. 1999. J. Biol. Chem. 274, 9116.
      Lohrke, B., et al. 1998. J. Endocrinol. 159, 429.
      Willson, T.M., et al. 1996. J. Med. Chem. 39, 665.
      Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977.
      Product Information
      CAS number74772-77-3
      ATP CompetitiveN
      FormWhite to tan solid
      Hill FormulaC₁₈H₂₃NO₃S
      Chemical formulaC₁₈H₂₃NO₃S
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetSelective PPARγ agonist
      Primary Target IC<sub>50</sub>EC50 = 3 µM as PPARγ agonist
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSXJ5813700
      Safety Information
      R PhraseR: 20/21/22

      Harmful by inhalation, in contact with skin and if swallowed.
      S PhraseS: 36

      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsStock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      230950-5MGCN 04055977218312

      Documentation

      Ciglitazone - CAS 74772-77-3 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Ciglitazone - CAS 74772-77-3 - Calbiochem 試験成績書(CoA)

      タイトルロット番号
      230950

      参考資料

      参考資料の概要
      Jha, R.J. 1999. Clin. Exp. Hypertens. 21, 157.
      Xin, X., et al. 1999. J. Biol. Chem. 274, 9116.
      Lohrke, B., et al. 1998. J. Endocrinol. 159, 429.
      Willson, T.M., et al. 1996. J. Med. Chem. 39, 665.
      Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-January-2020 JSW
      Synonyms(±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione, PPAR Agonist II, PPARγ Agonist I
      DescriptionA potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective peroxisome proliferator-activated receptor γ (PPARγ) agonist (EC50 = 3 µM).
      FormWhite to tan solid
      CAS number74772-77-3
      RTECSXJ5813700
      Chemical formulaC₁₈H₂₃NO₃S
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (≥ 25 mg/ml) or Ethanol (≥25 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsStock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful
      ReferencesJha, R.J. 1999. Clin. Exp. Hypertens. 21, 157.
      Xin, X., et al. 1999. J. Biol. Chem. 274, 9116.
      Lohrke, B., et al. 1998. J. Endocrinol. 159, 429.
      Willson, T.M., et al. 1996. J. Med. Chem. 39, 665.
      Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977.